Journal for ImmunoTherapy of Cancer (Nov 2023)

700 A phase II trial of MOnaliZumab plus durvAlumab plus platinum-based chemotheRapy for first-line treatment of extensive stage small cell lung cancer (MOZART): A Hoosier Cancer Research Network study

  • Seongho Kim,
  • Jie Chi,
  • Hirva Mamdani,
  • Shadia I Jalal,
  • Kristen Pizana,
  • Qura Abid

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0700
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.